Hercules Capital Inc HTGC

NYS: HTGC | ISIN: US4270965084 3/07/2025

18,61 USD (+0,11%)

(+0,11%) 3/07/2025

Grafiek Hercules Capital Inc

Grafiek Hercules Capital Inc

1 dag1d 0,11%
1 week1w 2,59%
1 maand1m 5,02%
3 maanden3m 8,26%
6 maanden6m -8,01%
1 jaar1j -12,30%
5 jaar5j 80,15%

Hercules Capital Inc in het nieuws

Toon enkel gratis nieuws

17 juli 2024 · Pindrop Secures $100 Million Financing To Accelerate Fraud And Deepfake Detection Technologies · Persbericht

14 mei 2024 · Harness Raises $150 Million in New Financing · Persbericht

30 april 2024 · SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab · Persbericht

22 december 2023 · enGene Announces Expanded $50 Million Debt Facility with Hercules Capital · Persbericht

24 juli 2023 · Heron Therapeutics Announces $30 Million Private Placement Financing · Persbericht

15 mei 2023 · Tipalti Secures $150 Million in Growth Financing from JPMorgan Chase Bank and Hercules Capital · Persbericht

14 maart 2023 · EPAM Welcomes DeAnne Aguirre to its Board of Directors · Persbericht

14 maart 2023 · Gibraltar Business Capital Launches Gibraltar Equipment Finance · Persbericht

2 februari 2023 · Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD® · Persbericht

16 november 2022 · Oak Street Health Secures $300 Million in Financing from Hercules Capital and Silicon Valley Bank · Persbericht

Profiel Hercules Capital Inc

Beleggingsbeheerders

Effecten- en grondstoffenbeurzen

Financiën en verzekeringen

Website: www.htgc.com

Hoofdzetel: Palo Alto, California Verenigde Staten

CEO: Scott Bluestein

Werknemers: 171

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe